How should I interpret a BUN of 19 mg/dL (normal), creatinine of 1.32 mg/dL (slightly elevated), eGFR of 57 mL/min/1.73 m² (reduced), and a BUN/creatinine ratio of 14 (normal) in this patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Interpretation: Stage G3a Chronic Kidney Disease with Mild Renal Impairment

These laboratory values indicate Stage G3a chronic kidney disease (CKD) with an eGFR of 57 mL/min/1.73 m², which falls below the diagnostic threshold of 60 mL/min/1.73 m² and represents mildly-to-moderately decreased kidney function. 1

Key Laboratory Findings Analysis

Your results show:

  • BUN 19 mg/dL (normal): Within normal range, indicating no significant accumulation of nitrogenous waste
  • Creatinine 1.32 mg/dL (slightly elevated): Minimally above the upper limit, reflecting reduced kidney filtration
  • eGFR 57 mL/min/1.73 m²: This is the most critical value—it places you in CKD Stage G3a (45-59 mL/min/1.73 m²) 1
  • BUN/Creatinine ratio 14 (normal): This normal ratio (reference 6-22) rules out prerenal causes of kidney dysfunction such as dehydration or gastrointestinal bleeding 2

Clinical Significance

The eGFR is the definitive measure of kidney function, not creatinine alone. 1 An eGFR below 60 mL/min/1.73 m² represents less than half of normal young adult kidney function (approximately 125 mL/min/1.73 m²) and carries clinically significant implications including:

  • Increased risk for drug toxicity (requiring medication dose adjustments)
  • Higher cardiovascular disease risk
  • Increased all-cause mortality risk
  • Potential for metabolic and endocrine complications 1

The normal BUN/creatinine ratio confirms this is intrinsic renal disease rather than prerenal azotemia (which would show a ratio >25:1) or acute dehydration. 2

Required Next Steps

You need annual monitoring at minimum, with assessment of both eGFR and albuminuria (urine albumin-to-creatinine ratio). 3 The KDIGO guidelines specifically recommend:

  1. Obtain urine albumin-to-creatinine ratio (ACR) if not already done—this is essential for complete CKD staging and risk stratification 1

  2. Identify the underlying cause of CKD (diabetes, hypertension, glomerular disease, etc.)—this is fundamental for guiding treatment 1

  3. Monitor for progression: CKD progression is defined as:

    • A sustained decline in eGFR >5 mL/min/1.73 m²/year (rapid progression)
    • A drop in GFR category with ≥25% decline from baseline 3
  4. Increase monitoring frequency if you have risk factors for progression (diabetes, hypertension, proteinuria) 3

Important Caveats

  • Single measurements can fluctuate: Small variations in eGFR are common and don't necessarily indicate progression. Confirm this finding with repeat testing in 3 months if this is your first abnormal result. 3

  • The eGFR calculation has limitations: It may underestimate kidney function in certain populations, though values >63.5 mL/min/1.73 m² can still occur in healthy adults. 4 However, your value of 57 is definitively below this threshold.

  • An eGFR >60 does not exclude kidney disease, but your value of 57 combined with elevated creatinine confirms reduced kidney function. 4

Related Questions

In a 76-year-old patient with a serum creatinine of 0.56 mg/dL and a BUN/creatinine ratio of 23, what is the appropriate management?
What is the normal BUN/creatinine ratio and how are elevated or decreased ratios interpreted in clinical practice?
In an 82‑year‑old long‑term‑care resident, how should an elevated BUN and high BUN‑to‑creatinine ratio with otherwise normal laboratory values and slightly low serum osmolality be interpreted?
In a 57-year-old woman with blood urea nitrogen (BUN) 17 mg/dL, serum creatinine 0.64 mg/dL, estimated glomerular filtration rate (eGFR) 103 mL/min/1.73 m², and BUN-to-creatinine ratio 27, what is the clinical significance and recommended management?
What does an elevated BUN with normal creatinine, high BUN/creatinine ratio, low total CO₂, and isolated alkaline phosphatase elevation indicate, and what management steps are recommended?
What are the possible causes of white patches on the posterior oral mucosa, and how should they be evaluated and treated?
In an 87-year-old female with major depressive disorder, Alzheimer’s disease with mild dementia and behavioral disturbances (agitation, anxiety, insomnia, wandering, restlessness) currently prescribed sertraline, brexpiprazole, quetiapine, divalproex sodium, trazodone, and melatonin, who is experiencing increased agitation, medication refusal, and difficulty being redirected, what additional assessments or non‑pharmacologic strategies should be considered?
Can white patches on the posterior oral mucosa be a manifestation of a Chlamydia trachomatis infection?
For a 62‑year‑old patient presenting with back pain, how should the lumbar magnetic resonance imaging (MRI) findings—specifically a left subarticular disc protrusion at L5‑S1 causing severe left subarticular zone stenosis and foraminal stenosis, and a diffuse disc bulge with central protrusion at L4‑L5—be interpreted?
What are the recommended medications and dosing for acute group A streptococcal infection?
Does Pepsi Zero increase insulin secretion?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.